28/01/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

28/01/2024

Jan 28, 2024, 19:07 | Blog
Omar Alhalabi: Matt needs no intro
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X post by…
Jan 28, 2024, 18:54 | Societies
10 posts from ASCO GU 2024 by Yüksel Ürün
Yüksel Ürün, Professor of Medical Oncology at Ankara University, has recapped ASCO GU highlights on…
Jan 28, 2024, 18:47 | Opinion
Daniel Stover: Excited to see early output from our Breast Cancer CNS Metastasis Group
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jan 28, 2024, 18:44 | Blog
Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News
Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…
Jan 28, 2024, 18:40 | Blog
The International Association for the Study of Lung Cancer logo for the first World Conference on Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) shared a post on X/Twitter:…
Jan 28, 2024, 18:36 | Blog
Mark Lewis: Last Supper
Mark Lewis shared a post on his X/Twitter page: "I don’t know how much you’ve…
Jan 28, 2024, 18:29 | Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Jan 28, 2024, 18:25 | Blog
Time to start a new and exciting project - giving a voice to childhood cancer survivors - POINTE
Quoting POINTE on X/Twitter: "Time to start a new and exciting project - giving a…
Jan 28, 2024, 18:20 | Blog
Michael Dickinson: So pleased to work with a great team of authors from around the world on these recommendations for bispecifics
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, shared a post on X/Twitter: "So pleased to work…
Jan 28, 2024, 18:17 | Blog
Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter: "Our metanalysis…
All: 36 Posts: 1 - 10